Induction of PNAd and N-acetylglucosamine 6-O-sulfotransferases 1 and 2 in mouse collagen-induced arthritis

Por Yang, Jiwei, Rosen, Steven D, Bendele, Philip, Hemmerich, Stefan
Publicado em 2006

Sulfation of a High Endothelial Venule–Expressed Ligand for L-Selectin: Effects on Tethering and Rolling of Lymphocytes

Por Tangemann, Kirsten, Bistrup, Annette, Hemmerich, Stefan, Rosen, Steven D.
Publicado em 1999

Therapeutic Targeting of Endothelial Ligands for L-selectin (PNAd) in a Sheep Model of Asthma

Por Rosen, Steven D., Tsay, Durwin, Singer, Mark S., Hemmerich, Stefan, Abraham, William M.
Publicado em 2005

Cloning and Characterization of Two Extracellular Heparin-degrading Endosulfatases in Mice and Humans

Por Morimoto-Tomita, Megumi, Uchimura, Kenji, Werb, Zena, Hemmerich, Stefan, Rosen, Steven D.
Publicado em 2002

Oral Hypoxia‐Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG‐4592) for Treatment of Anemia in Chronic Kidney Disease: A Placebo‐Controlled Study of Pharmacokinetic and...

Por Provenzano, Robert, Tumlin, James, Zabaneh, Raja, Chou, James, Hemmerich, Stefan, Neff, Thomas B., Yu, K.‐H. Peony
Publicado no J Clin Pharmacol (2020)

Functional Contributions of N- and O-Glycans to L-Selectin Ligands in Murine and Human Lymphoid Organs

Por Arata-Kawai, Hanayo, Singer, Mark S., Bistrup, Annette, Zante, Annemieke van, Wang, Yang-Qing, Ito, Yuki, Bao, Xingfeng, Hemmerich, Stefan, Fukuda, Minoru, Rosen, Steven D.
Publicado em 2011

Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients

Por Besarab, Anatole, Provenzano, Robert, Hertel, Joachim, Zabaneh, Raja, Klaus, Stephen J., Lee, Tyson, Leong, Robert, Hemmerich, Stefan, Yu, Kin-Hung Peony, Neff, Thomas B.
Publicado no Nephrol Dial Transplant (2015)

Sulfotransferases of Two Specificities Function in the Reconstitution of High Endothelial Cell Ligands for L-selectin

Por Bistrup, Annette, Bhakta, Sunil, Lee, Jin Kyu, Belov, Yevgeniy Y., Gunn, Michael Dee, Zuo, Feng-Rong, Huang, Chiao-Chain, Kannagi, Reiji, Rosen, Steven D., Hemmerich, Stefan
Publicado em 1999

Roxadustat (FG-4592): Correction of Anemia in Incident Dialysis Patients

Por Besarab, Anatole, Chernyavskaya, Elena, Motylev, Igor, Shutov, Evgeny, Kumbar, Lalathaksha M., Gurevich, Konstantin, Chan, Daniel Tak Mao, Leong, Robert, Poole, Lona, Zhong, Ming, Saikali, Khalil G., Franco, Marietta, Hemmerich, Stefan, Yu, Kin-Hung Peony, Neff, Thomas B.
Publicado no J Am Soc Nephrol (2016)

Oral Hypoxia–Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD

Por Provenzano, Robert, Besarab, Anatole, Sun, Chao H., Diamond, Susan A., Durham, John H., Cangiano, Jose L., Aiello, Joseph R., Novak, James E., Lee, Tyson, Leong, Robert, Roberts, Brian K., Saikali, Khalil G., Hemmerich, Stefan, Szczech, Lynda A., Yu, Kin-Hung Peony, Neff, Thomas B.
Publicado no Clin J Am Soc Nephrol (2016)

Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China

Por Chen, Nan, Qian, Jiaqi, Chen, Jianghua, Yu, Xueqing, Mei, Changlin, Hao, Chuanming, Jiang, Gengru, Lin, Hongli, Zhang, Xinzhou, Zuo, Li, He, Qiang, Fu, Ping, Li, Xuemei, Ni, Dalvin, Hemmerich, Stefan, Liu, Cameron, Szczech, Lynda, Besarab, Anatole, Neff, Thomas B., Peony Yu, Kin-Hung, Valone, Frank H.
Publicado no Nephrol Dial Transplant (2017)